Skip to content
buyWeak

Michael Heltzen bought $22k of EXOZ

Chief Executive Officer at EXOZYMES INC.. 1,984 shares at an average of $11.10, traded Nov 15, 2024, filed Nov 19, 2024.

Conviction score
33
Value
$22k
1,984 shares
Holdings after
1,984
change unknown
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    CEO
    +25
  • Trade size
    $22k at market
    0
  • Relative to holdings
    First purchase: no shares before this trade
    +8
  • Price context
    No price history yet
    0
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001493152-24-046902, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Nov 15, 2024POpen-market purchase
Common Stock
+1,984$11.10$22k1,984Nov 19, 2024

Related signals

Other insiders at EXOZYMES INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
28Weak
EXOZbuy
EXOZYMES INC.
Michael Heltzen
Chief Executive Officer
$6,405
855 shares
+6%
15Weak
EXOZsell
EXOZYMES INC.
Tyler Paz Korman
Chief Scientific Officer
$15k
1,500 shares
-0%
36Weak
EXOZbuy
EXOZYMES INC.
Michael Heltzen
Chief Executive Officer
$11k
1,040 shares
+11%
40Moderate
EXOZbuy
EXOZYMES INC.
Michael Heltzen
Chief Executive Officer
$20k
1,888 shares
+95%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Michael Heltzen bought $22k of EXOZ | InsiderTell